Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2004-05-28
2010-06-01
Brusca, John S (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C365S094000, C700S001000
Reexamination Certificate
active
07729864
ABSTRACT:
Methods, computer program products and systems for identifying cellular constituents in a secondary tissue that serve as surrogate markers for a target gene expressed in a primary tissue of a species are provided. A classifier is constructed using cellular constituent abundances of cellular constituents in a first plurality of cellular constituents measured in the secondary tissue in a population. This population comprises a first and second subgroup. The classifier is based on a second plurality of cellular constituents that comprises all or a portion of the first plurality of cellular constituents. Abundance levels of each cellular constituent in the second plurality of cellular constituents varies between the first and second subgroup. All or portion of the population is classified into a plurality of subtypes using the classifier. Then, one or more cellular constituents that can discriminate members of the population between a first subtype and a second subtype in the plurality of subtypes are identified.
REFERENCES:
patent: 5075217 (1991-12-01), Weber
patent: 5324631 (1994-06-01), Helentjaris et al.
patent: 5510270 (1996-04-01), Fodor et al.
patent: 5569588 (1996-10-01), Ashby et al.
patent: 5578832 (1996-11-01), Trulson et al.
patent: 5965352 (1999-10-01), Stoughton et al.
patent: 6132969 (2000-10-01), Stoughton et al.
patent: 6132997 (2000-10-01), Shannon
patent: 6165709 (2000-12-01), Friend et al.
patent: 6218122 (2001-04-01), Friend et al.
patent: 6271002 (2001-08-01), Linsley et al.
patent: 6324479 (2001-11-01), Friend et al.
patent: 6368806 (2002-04-01), Openshaw et al.
patent: 2003/0180761 (2003-09-01), Castonguay et al.
patent: 2003/0224394 (2003-12-01), Schadt et al.
patent: 2006/0111849 (2006-05-01), Schadt et al.
patent: 2006/0122816 (2006-06-01), Schadt et al.
patent: WO 9913107 (1999-03-01), None
patent: WO 03065282 (2003-08-01), None
patent: WO 03100557 (2003-12-01), None
patent: WO 2004013727 (2004-02-01), None
patent: WO 2004 061616 (2004-07-01), None
patent: WO 2004 109447 (2004-12-01), None
patent: WO 2005 017652 (2005-02-01), None
patent: WO 2005 107412 (2005-11-01), None
Tang et al. Blood Genomic Responses Differ After Stroke, Seizures, Hypoglycemia, and Hypoxia: Blood Genomic Fingerprints of Disease Annals of Neurology vol. 50, pp. 699-707 (2001).
U.S. Appl. No. 11/361,871, filed Feb. 23, 2006, Schadt et al.
U.S. Appl. No. 10/558,928, filed Nov. 30, 2005, Schadt et al.
U.S. Appl. No. 10/540,405, filed Dec. 24, 2003, Schadt et al.
PCT/US05/15419, May 2, 2005, International Search Report.
PCT/US04/16917, May 28, 2004, International Search Report.
PCT/US03/03100, Feb. 3, 2003, International Search Report.
PCT/US03/023976, Aug. 1, 2003, International Search Report.
PCT/US03/41613, Dec. 24, 2003, International Search Report.
PCT/US03/15768, May 20, 2003, International Search Report.
Aitman et al., 1999, “Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats,” Nature Genetics 21: 76-83.
Akagi et al., 1996, “Microsatellite DNA markers for rice chromosomes,” Theor. Appl. Genet. 93:1071-1077.
Allison et al., 1998, “Multiple phenotype modeling in gene-mapping studies of quantitative traits: power advantages,” Am. J. Hum. Genet. 63:1190-1201.
Amos et al., 1990, “A multivariate method for detecting genetic linkage, with application to a pedigree with an adverse lipoprotein phenotype,” Am. J. Hum. Genet. 47:247-254.
Barbosa et al., 1976, “The genetic heterogeneity of diabetes : histocompatibility antigens (HLA) in families with maturity-onset type diabetes of the young (MODY) and juvenile, insulin-dependent diabetes (JID) [proceedings],” Diabete. Metab. 2:160.
Blanchard et al., 1996, “Sequence to array: Probing the genome's secrets,” Nature Biotechnology 14:1649.
Blanchard et al., 1996, “High-density oligonucleotide arrays,” Biosensors & Bioelectronics 11: 687-690.
Bligh et al, 1995, “A microsatellite sequence closely linked to the Waxy gene ofOryza sativa,” Euphytica 86:83-85.
Bochner et al., 2001, “Phenotype microarrays for high-throughput phenotypic testing and assay of gene function,” Genome Res. 11:1246-1255.
Börjeson, 1976, “The aetiology of obesity in children,” Acta. Paediar. Scand. 65:279-287.
Bray, 1989, “1989 McCollum Award Lecture. Genetic and hypothalamic mechanisms for obesity-finding the needle in the haystack,” Am. J. Clin. Nutr. 50:891-902.
Bray, 1992, “Genetic, hypothalamic and endocrine features of clinical and experimental obesity,” Progress in Brain Research 93:333-341.
Brem et al., 2002, “Genetic Dissection of Transcriptional Regulation in Budding Yeast,” Science 296:752-755.
Brown et al., 2000, “Knowledge-based analysis of microarray gene expression data by using support vector machines,” Proc. Natl. Acad. Sci. USA 97:262-267.
Cheung et al., 2002, “The genetics of variation in gene expression,” Nature Genetics Supplement 32: 522-525.
Cheung et al., 2003, “Natural variation in human gene expression assessed in lymphoblastoid cells,” Nature Genetics 33: 422-425.
Chirgwin et al., 1979, “Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease,” Biochemistry 18:5294-5299.
Cohen et al., 2000, “A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression,” Nature Genetics 26:183-186.
Corder et al., 1993, “Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families,” Science 261:921-923.
Cox et al., 1999, “Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans,” Nature Genetics 21:213-215.
DeRisi et al., 1996, “Use of a cDNA microarray to analyse gene expression patterns in human cancer,” Nature Genetics 14:457-460.
Doerge, 2002, “Mapping and analysis of quantitative trait loci in experimental populations,” Nature Reviews 3:43-52.
Draghici, 2003, “Data Analysis Tools for DNA Microarrays,” Chapman & Hall, p. 1-478.
Duda et al., 2001, Pattern Classification, John Wiley & Sons, New York, NY, p. 521-530.
Duda et al., 2001, Pattern Classification, John Wiley & Sons, New York, NY, p. 550-557.
Easton et al., 1993, “Inherited susceptibility to breast cancer,” Cancer Surv. 18:95-113.
Eaves et al., 2002, “Combining Mouse Congenic Strains and Microarray Gene Expression Analyses to Study a Complex Trait: The NOD Model of Type 1 Diabetes,” Genome Research 12: 232-243.
Egholm et al., 1993, “PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules,” Nature 365:566-568.
Elowitz et al., 2002, “Stochastic Gene Expression in a Single Cell,” Science 297:1183-1186.
Falk et al., 1987, “Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations,” Ann. Hum. Genet. 51 ( Pt 3):227-233.
Ferguson et al., 1996, “A fiber-optic DNA biosensor microarray for the analysis of gene expression,” Nature Biotechnology 14:1681-1684.
Fiehn et al., 2000, “Metabolite profiling for plant functional genomics,” Nature Biotech. 18:1157-1161.
Fishel et al., 1993, “The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer,” Cell 75:1027-1038.
Fodor et al., 1991, “Light-directed, spatially addressable parallel chemical synthesis,” Science 251:767-773.
Ford et al., 1994, “Risks of cancer in BRCA1—mutation carriers. Breast Cancer Linkage Consortium,” Lancet 343:692-695.
Friedman et al., 1991, “Molecular mapping of obesity genes,” Mammalian Genome 1:130-144.
Friedman et al., 1992, “Tackling a weighty problem,” Cell 69:21
Brusca John S
Christensen O'Connor Johnson & Kindness PLLC
Merck Sharp & Dohme Corp.
LandOfFree
Computer systems and methods for identifying surrogate markers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Computer systems and methods for identifying surrogate markers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Computer systems and methods for identifying surrogate markers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4179931